Halozyme Therapeutics Inc.

XNAS: HALO

Expensive Performer

Download real time

60.22 2.52 (4.37%)

59.61% Gain from 52W Low

1.8M XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

7,439.2

Market Cap

High in industry

0.2

Beta 1Year

Very Low volatility

Halozyme Therapeutics Inc. - HALO - stock price prediction, stock price target, analyst ratings from 9 analysts

Halozyme Therapeutics Inc. has a share price target of US$ 68, revenue growth forecast of 16.8%, and profit growth estimate of 25.9% for FY25, based on top 9 analyst calls.

Forecaster Screeners